CTOR: Pangali rega marang bathi tumrap wutah citiusonc.com
Strong physician confidence positions Citius Oncology, Inc. (CTOR) as a promising niche leader. This chart on GURU.Markets shows that the normalized PEG ratio confirms this potential, with the parameter reaching 0.00. Growth is driven by the expansion of LYMPHIR into US hospitals, the establishment of supply chains for lymphoma therapies, and the development of a pipeline of targeted drugs for rare forms of cancer.
Rincian analitis perusahaan Citius Oncology, Inc. (CTOR)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Citius Oncology, Inc.|CTOR - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas citiusonc.com|CTOR - Gunggung utang perusahaan|Utang-utang marang aset resik Citius Oncology, Inc|CTOR - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Citius Oncology|Koefisien jangkoan perantara citiusonc.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CTOR - Penghasilan resik|Proyeksi bathi mangsa ngarep Citius Oncology, Inc.|CTOR - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Citius Oncology Inc|CTOR - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Citius Oncology, Inc|CTOR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Citius Oncology|CTOR - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan citiusonc.com|CTOR - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Citius Oncology, Inc.
Analisis umum perusahaan:CTOR, Citius Oncology Inc.
Citius Oncology, Inc. (CTOR) is developing innovative immunotherapy for bladder cancer, where future insurance reimbursements determine the business's scaling potential. This PEG ratio compares the stock's market value with its earnings growth rate, making it possible to identify undervalued assets. Values below one on this chart signal high investment attractiveness for the issuer relative to its expansion within the oncology sector.
Karo sapa Citius Oncology, Inc. saingan
ONC (BeiGene Ltd.) - Koefisien bali modal nimbang wutah|Pangali PEG HALO (Halozyme Inc.)|RVMD - Pangali rega marang bathi tumrap wutah|AAPG: Pangali rega marang bathi tumrap wutah|CGON - Pangali PEG|UroGen Pharma (URGN) - Rasio rega marang bathi tumrap wutah|Bicara Therapeutics Inc - Koefisien bali modal nimbang wutah|PSNL (Personalis Corp) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Erasca Oncology ERAS|Pangali PEG DCTH|Pangali rega marang bathi tumrap wutah ymabs.com YMAB|Pangali PEG AURA (Aura Biosciences)|Kapitalisasi marang bathi resik kanthi nimbang wutah Candel Therapeutics Inc. (CADL)|ARAY: Pangali rega marang bathi tumrap wutah|SELLAS Life Sciences - Rasio nilai perusahaan marang wutah bathi|ACTU: Pangali PEG|HURA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah TARA|Pangali PEG Fate Therapeutics Inc|Rasio rega marang bathi tumrap wutah Aadi Bioscience Inc (WHWK)|Kapitalisasi marang bathi resik kanthi nimbang wutah tscan.com|Champions Oncology, Inc. - Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah XBIT|CVM - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah OS Therapies Inc.|Radiopharm Theranostics Limited (RADX) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah ARTV|ANL (Adlai Nortye Ltd) - Pangali PEG|Pangali rega marang bathi tumrap wutah verupharma.com (VERU)|Rasio rega marang bathi tumrap wutah Tempest Therapeutics, Inc. (TPST)|XLO - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Renovaro RENB|Mural Oncology PLC - Rasio rega marang bathi tumrap wutah|KAPA - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah OnKure Therapeutics Inc|GDTC: Pangali PEG|Rasio rega marang wutah bathi resik Curis CRIS|Pangali rega marang bathi tumrap wutah APLM|Rega marang bathi kanthi panyesuaian wutah Tharimmune Corporation THAR|Pangali rega marang bathi tumrap wutah ADVB (Advanced Biomed Inc)|GNPX (genprex.com) - Koefisien bali modal nimbang wutah|Pangali PEG CLDI (Calidi Biotherapeutics, Inc.)|Kapitalisasi marang bathi resik kanthi nimbang wutah Sunshine Biopharma Inc. (SBFM)|XBIO - Rasio rega marang bathi tumrap wutah|SLRX (Salarius Pharma) - Rasio P/E diaturake wutah|PPBT: Pangali PEG|Pangali rega marang bathi tumrap wutah American Oncology Network, Inc.|Pangali rega marang bathi tumrap wutah BGNE|Checkpoint Therapeutics Inc. (CKPT) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali PEG ELEV|Pangali rega marang bathi tumrap wutah icadmed.com ICAD|Ikena Oncology - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi NTBL (notablelabs.com)|VIRX - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah MorphoSys Inc|NAYA Bio (NAYA) - Rasio rega marang bathi tumrap wutah|Ascentage - Koefisien bali modal nimbang wutah
